RecruitingNCT05766007
Long-acting Injectable Antipsychotics for Mental Ill-Health in Pregnancy and Postpartum
Studying Postpartum psychosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Liverpool
- Principal Investigator
- Adeniyi Olagunju, PhDUniversity of Liverpool
- Enrollment
- 125 target
- Eligibility
- 18-49 years · FEMALE
- Timeline
- 2023 – 2026
Study locations (6)
- Federal Medical Centre, Makurdi, Benue State, Nigeria
- Federal Neuropsychiatric Hospital, Kaduna, Kaduna State, Nigeria
- Federal Neuropsychiatric Hospital, Yaba, Lagos, Nigeria
- Neuropsychiatric Hospital, Abeokuta, Ogun State, Nigeria
- Neuropsychiatric Specialist Hospital, Akure, Ondo State, Nigeria
- Obafemi Awolowo University Teaching Hospital, Ile-Ife, Osun State, Nigeria
Collaborators
Federal Neuropsychiatric Hospital, Yaba · Federal Neuropsychiatric Hospital, Kaduna · Neuropsychiatric Hospital, Abeokuta · Neuropsychiatric Specialist Hospital, Akure · Obafemi Awolowo University Teaching Hospital · Federal Medical Centre, Makurdi
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05766007 on ClinicalTrials.gov